Skip to main content

Table 4  Diagnostic performance of predictive models for differentiation of ROs and RCCs

From: CT differentiation of the oncocytoma and renal cell carcinoma based on peripheral tumor parenchyma and central hypodense area characterisation

Model parameter

Model−1

Model−1*

Model−1*validation

Model−2

Model−2*

Model−2*validation

Sensitivity

0.783(18/23)

0.826(19/23)

0.875(7/8)

0.783(18/23)

0.826(19/23)

0.750(6/8)

Specificity

0.953(81/85)

0.965(82/85)

0.829(29/35)

0.833(20/24)

0.875(21/24)

0.900(9/10)

PPV

0.818(18/22)

0.864(19/22)

0.538(7/13)

0.818(18/22)

0.864(19/22)

0.857(6/7)

NPV

0.942(81/86)

0.953(82/86)

0.967(29/30)

0.800(20/25)

0.840(21/25)

0.818(9/11)

Accuracy

0.917(99/108)

0.935(101/108)

0.837(36/43)

0.809(38/47)

0.851(40/47)

0.833(40/47)

AUC

0.952

0.962

0.936

0.839

0.914

0.938

AUC(95% CI)

0.912–0.992

0.925–0.999

0.860-1.000

0.722–0.955

0.828-1.000

0.825-1.000

  1. Model-1 and Model-2 are predictive models excluding CT features of CHA for differentiating RO from ccRCC and non-ccRCC, respectively. Model-1* and Model-2* are predictive models including CT features of CHA for differentiating RO from ccRCC and non-ccRCC, respectively
  2. Model−1*validation and Model−2*validation are the test results of Model-1* and Model-2* on the validation dataset, respectively
  3. Values are ratios of the numerator and denominator in parentheses
  4. AUC Area under curve,  CI Confidence interval,  CHA Central hypodense area,  ccRCC Clear cell renal cell carcinoma,  NPV Negative predictive value, PPV Positive predictive value,  RO Renal oncocytoma,  RCC Renal cell carcinoma